The Georgia Life Sciences Summit 2002, which focuses on fostering the growth of Georgia’s life sciences industry, is set to return for its second running.
The summit will take place on Thursday, Sept. 26 at the Georgia World Congress Center in Atlanta. The Summit bills itself as the primary gathering of scientists and industry decision makers for Georgia’s life sciences community.
Georgia Life Sciences Summit 2002 will include company presentations, international partnering, networking, panel discussions and exhibits to salute and showcase the life sciences industry in Georgia. This year’s summit will feature remarks from Carl Feldbaum, president of Biotechnology Industry Organization (BIO), as well as presentations and exhibits from the leading life sciences companies in Georgia.
Other program highlights will include “The State of Georgia’s Life Sciences” by Robert McNally, chair of the Georgia Biomedical Partnership, which established the event last year; a series of four concurrent sessions ranging on topics from research and development to biomanufacturing; and the Georgia Company Panel, featuring Nadine Craig, vice president of sales and marketing for UCB Pharma, a sponsor of the event; John W. Sharkey, vice president of business development and licensing with Novartis; and David Dodd, president and chief executive officer of Serologicals, another event sponsor.
“Georgia’s life sciences industry is ranked ninth in the United States, and with over 100 companies in Georgia dedicated to this growing business sector, we are proud to be part of one of the fastest growing life sciences industries in the nation,” Dodd said in a statement.
Sessions for the Life Sciences Summit will be held from 8:15 AM until 8 PM. For further information, contact the Georgia Biomedical Partnership at 404-221-0617, or the Web site.
Georgia Life Sciences Summit 2002: www.gabio.org/lifesummit2002.asp